Physician profile
Mikal A Bailey
NPI 1972570596
$84,106.60
in general payments reported to CMS, 2019-2025
49 companies · $59K in 2025
The $59K reported for 2025 was more than what 99% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13K · 2022: $2,924 · 2023: $3,329 · 2024: $5,335 · 2025: $59K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $49K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,890 · Food and Beverage: $5,414 · Travel and Lodging: $3,594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $49,243.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,890.00 |
| Food and Beverage | $5,413.59 |
| Travel and Lodging | $3,593.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $50,772.60 | 2022-2025 | Neurostar Tms Therapy System |
| Janssen Pharmaceuticals, INC | $15,251.81 | 2022-2025 | Spravato |
| Abbvie INC. | $6,402.54 | 2021-2024 | |
| Allergan, INC. | $3,991.99 | 2021 | |
| Brainsway USA INC | $2,032.78 | 2024-2025 | Brainsway Deep Tms System, Deep Tms |
| Novartis Pharmaceuticals Corporation | $790.52 | 2021-2025 | |
| Biogen, INC. | $643.60 | 2021-2023 | Tysabri, Vumerity |
| Biohaven Pharmaceuticals, INC. | $600.65 | 2021 | |
| Emd Serono, INC. | $337.62 | 2021-2023 | Mavenclad |
| Neurelis, INC. | $296.08 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $260.75 | 2021-2023 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $249.29 | 2022 | |
| Avanir Pharmaceuticals, INC. | $237.84 | 2021-2022 | |
| Eisai INC. | $183.64 | 2021-2023 | |
| Inspire Medical Systems, INC. | $156.07 | 2022-2023 | Inspire |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mikal Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.